© 2021 MJH Life Sciences and Cure Today. All rights reserved.
© 2021 MJH Life Sciences™ and Cure Today. All rights reserved.
June 5th 2021, 5:00pm
Progression-free survival improved with Zejula compared with placebo in patients with BRCA-mutated ovarian cancer with no new safety signals.
June 1st 2021, 6:00pm
Each month, we take a look back at the most popular CURE® stories. Here are the top five stories for May 2021.
May 27th 2021, 6:00pm
Evidence from a phase 3 trial does not support the addition of Tecentriq to a specific chemotherapy regimen with Avastin for patients with newly diagnosed stage 3 or 4 ovarian cancer.
May 25th 2021, 9:00pm
This maintenance therapy approach approved progression-free survival without a major impact on quality of life in patients with newly diagnosed ovarian cancer with a BRCA mutation who recently responded to chemotherapy.
May 25th 2021, 1:00pm
Vulnerable older patients with advanced ovarian cancer do not respond well to carboplatin treatment alone compared to a combination with paclitaxel.
May 13th 2021, 3:00pm
In this episode of the “CURE® Talks Cancer” podcast, Maria Ciesla, an ovarian cancer survivor, and her daughter Alex Cornwell discuss Ciesla’s cancer journey and how it led them to do genetic testing that revealed they were both carriers of the BRCA1 mutation.
May 8th 2021, 3:00pm
Today is World Ovarian Cancer Day, and in honor of this day that was created in 2013 to raise awareness about the disease, CURE® is rounding up the latest news and updates in this cancer space.
May 6th 2021, 4:00pm
“We’re all blessed that there are so many dedicated, caring health care professionals willing to step in and fill the void when members of the team move or retire,” writes a patient with cancer. “We can never forget how tough a gig it is or say thank you enough.”
May 2nd 2021, 3:00pm
Clinical trials are often the key to advancements in treating ovarian cancer. As part of its “Speaking Out” video series, CURE® spoke with Dr. Debra Richardson about what patients should know about joining a trial.
April 19th 2021, 6:00pm
On social media, CURE® recently asked its readers to share if they sought a second opinion when discussing their cancer diagnosis and treatment. Here’s what some of them said.
An Oncology Nurse Wears Many Hats
Inaccurate Information on Cancer Diagnosis and Treatment Common on Social Media Sites
Small-Town Cancer Team, Big Success
Grief Is Like Swimming